Corporate News     04-Mar-21
Alembic Pharmaceuticals JV receives USFDA final approval for Testosterone Gel
Alembic Pharmaceuticals announced that its joint venture Aleor Dermaceuticals (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation). The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), AndroGel 1.62%, of AbbVie Inc. (AbbVie). Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation) is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired) and Hypogonadotropic hypogonadism (congenital or acquired). Aleor had previously received tentative approval for this ANDA.

Testosterone Gel, 1.62% (20.25 mg/1.25 gm actuation) has an estimated market size of US$ 86 million for twelve months ending December 2020 according to IQVIA.

Alembic has a cumulative total of 138 ANDA approvals (122 final approvals and 16 tentative approvals) from USFDA.

Previous News
  Alembic Pharma gets USFDA nod for Icatibant injection
 ( Hot Pursuit - 17-Jun-24   14:03 )
  Alembic Pharmaceuticals receives USFDA approval (final & tentative) for 11 products
 ( Corporate News - 03-Jul-24   15:42 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Ribociclib Tablets
 ( Corporate News - 01-Apr-24   11:51 )
  Alembic Pharma's oncology formulation facility undergoes USFDA audit
 ( Corporate News - 09-Mar-24   12:26 )
  Alembic Pharmaceuticals Ltd leads losers in 'A' group
 ( Hot Pursuit - 09-Aug-24   15:00 )
  Volumes spurt at Blue Star Ltd counter
 ( Hot Pursuit - 20-Sep-23   14:30 )
  Alembic Pharmaceuticals to declare Quarterly Result
 ( Corporate News - 18-Apr-24   16:14 )
  Alembic Pharma’s Gujarat facility gets 4 observations from USFDA
 ( Hot Pursuit - 09-Mar-24   09:04 )
  Alembic Pharmaceuticals receives USFDA approval for Prazosin Hydrochloride Capsules
 ( Corporate News - 08-Mar-23   09:14 )
  Volumes soar at Timken India Ltd counter
 ( Hot Pursuit - 30-Nov-23   11:00 )
  Alembic Pharma gains as Karkhadi facility gets EIR from USFDA
 ( Hot Pursuit - 16-Feb-23   15:42 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top